Drug for low sexual desire carries significant harms, FDA advisers find

BMJ. 2010 Jul 7:341:c3339. doi: 10.1136/bmj.c3339.
No abstract available

Publication types

  • News

MeSH terms

  • Benzimidazoles / adverse effects*
  • Drug Approval
  • Female
  • Humans
  • Libido / drug effects*
  • Neurotransmitter Agents / adverse effects*
  • Premenopause
  • Sexual Dysfunction, Physiological / drug therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Benzimidazoles
  • Neurotransmitter Agents
  • flibanserin